Form4insider filings, from the source

Insider holders · CIK 0000786947

ACURA PHARMACEUTICALS, INC · ACUR

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
John Schutte10% Owner8,912,655—8,912,655Aug 2, 2017 · 5:05 pm EDTForm 3
Immanuel ThangarajDirector126,1921,956,3962,082,588Jan 8, 2019 · 4:38 pm ESTForm 4
Bruce F WessonDirector520,593—520,593Jan 8, 2019 · 4:31 pm ESTForm 4
James F EmighVP Corporate Development439,660—439,660Dec 18, 2017 · 6:09 am ESTForm 4
Robert B JonesPresident and CEO412,555—412,555Dec 15, 2017 · 4:21 pm ESTForm 4
Peter A ClemensSenior VP and CFO355,182—355,182Dec 15, 2017 · 4:23 pm ESTForm 4
Robert A SeiserVP, Controller & Treasurer322,490—322,490Dec 15, 2017 · 4:25 pm ESTForm 4
Albert W BrzeczkoVP Technical Affairs - APT316,000—316,000Dec 15, 2017 · 4:28 pm ESTForm 4
William G SkellyDirector254,534—254,534Jan 4, 2019 · 4:32 pm ESTForm 4
George K RossDirector211,005—211,005Jan 4, 2019 · 4:32 pm ESTForm 4
Galen Management, LLCrelationship not stated—00Jan 2, 2018 · 6:11 pm ESTForm 4
CLAUDIUS LLCrelationship not stated—00Jan 2, 2018 · 6:11 pm ESTForm 4
GALEN EMPLOYEE FUND III LPrelationship not stated—00Jan 2, 2018 · 6:11 pm ESTForm 4
GALEN PARTNERS INTERNATIONAL III L Prelationship not stated—00Jan 2, 2018 · 6:11 pm ESTForm 4
GALEN PARTNERS III L Prelationship not stated—00Jan 2, 2018 · 6:11 pm ESTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.